Medtronic (MDT) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $83.87 +1.80%
EPS Growth %: +10.3%
Financial Fact:
Selling, general, and administrative expense: 1.49B
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +10.3%
Financial Fact:
Selling, general, and administrative expense: 1.49B
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $6.93 billion versus the consensus estimate of $6.99 billion.
GUIDANCE:
Medtronic still sees FY16 EPS of $4.36 - $4.40, versus the consensus of $4.38.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic, Inc. (MDT) PT Lowered to $100 at TD Cowen
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
- Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
